ZITHROMAX

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Finland, France, Hong Kong, Ireland, Israel, Malta, Nigeria, Netherlands, New Zealand, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug ZITHROMAX contains one active pharmaceutical ingredient (API):

1 Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE

Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. Read about Azithromycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZITHROMAX Film-coated tablet / Powder for suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR
ZITHROMAX Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR
ZITHROMAX Capsule, hard	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4115N, 5616N, 6221K, 8200N, 8201P, 8336R
Country: CA	Health Products and Food Branch	Identifier(s): 02212021, 02223716, 02223724, 02239952
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00010760, 02481966, 04678503, 07130987
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 003742, 039776, 039784, 389452, 389460
Country: FR	Base de données publique des médicaments	Identifier(s): 62059468, 65740799, 67287098, 68175764
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139916, 164513, 19151, 19153, 19156, 19157, 19158, 375776, 381770, 381772, 381773
Country: HK	Department of Health Drug Office	Identifier(s): 36432, 44360, 44814, 45614
Country: IE	Health Products Regulatory Authority	Identifier(s): 59900, 59919, 91953, 91979
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8658
Country: MT	Medicines Authority	Identifier(s): MA505/03901, MA505/03902, PI1438/09901A, PI770/13801A, PI908/07601C, PI908/07602A
Country: NG	Registered Drug Product Database	Identifier(s): 04-1387, 04-1388
Country: NL	Z-Index G-Standaard	Identifier(s): 13810707
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 114995, 115002, 115010
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10223, 6161, 6162, 6163, 6164
Country: SG	Health Sciences Authority	Identifier(s): 07863P, 10720P, 10721P, 10911P, 12057P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6043171, 9243053, 9243054, 9243055, 9243056
Country: US	FDA, National Drug Code	Identifier(s): 0069-0400, 0069-3051, 0069-3060, 0069-3070, 0069-3110, 0069-3120, 0069-3130, 0069-3140, 0069-3150, 0069-4061, 50090-0603, 61919-555, 70518-0336, 70518-0505
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/20.1.1/0279, 31/20.1.1/0045, 36/20.1.1/0190, A40/20.1.1/0102